Home / Uncategorized / Panel advises FDA to approve lorcaserin obesity pill

Panel advises FDA to approve lorcaserin obesity pill

Panel voted 18-4 with one abstention to recommend approval of Arena’s lorcaserin, concluding its benefits “outweigh the potential risks when used long term” in overweight and obese people

Continue reading here:
Panel advises FDA to approve lorcaserin obesity pill

If you enjoyed this post, make sure you subscribe to my RSS feed!

About Philippe Matthews

Scroll To Top